Thoughts on a favourable evolution of a COVID-19 in a patient with resistant schizophrenia and on a combination of clozapine and paliperidone palmitate
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
|---|---|
| Enthalten in: |
L'Encephale - 46(2020), 3S vom: 23. Juni, Seite S126-S127 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Réflexions autour d’une évolution favorable d’une COVID-19 chez un patient présentant une schizophrénie résistante et sous une association clozapine et palipéridone palmitate |
|---|
| Beteiligte Personen: |
Bouaziz, N [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 17.07.2020 Date Revised 10.01.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.encep.2020.05.009 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM310561345 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM310561345 | ||
| 003 | DE-627 | ||
| 005 | 20231225140350.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.encep.2020.05.009 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1035.xml |
| 035 | |a (DE-627)NLM310561345 | ||
| 035 | |a (NLM)32475694 | ||
| 035 | |a (PII)S0013-7006(20)30094-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Bouaziz, N |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Thoughts on a favourable evolution of a COVID-19 in a patient with resistant schizophrenia and on a combination of clozapine and paliperidone palmitate |
| 246 | 3 | 3 | |a Réflexions autour d’une évolution favorable d’une COVID-19 chez un patient présentant une schizophrénie résistante et sous une association clozapine et palipéridone palmitate |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.07.2020 | ||
| 500 | |a Date Revised 10.01.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Anticonvulsants |2 NLM | |
| 650 | 7 | |a Antipsychotic Agents |2 NLM | |
| 650 | 7 | |a Delayed-Action Preparations |2 NLM | |
| 650 | 7 | |a Immunologic Factors |2 NLM | |
| 650 | 7 | |a Lithium Carbonate |2 NLM | |
| 650 | 7 | |a 2BMD2GNA4V |2 NLM | |
| 650 | 7 | |a Valproic Acid |2 NLM | |
| 650 | 7 | |a 614OI1Z5WI |2 NLM | |
| 650 | 7 | |a Clozapine |2 NLM | |
| 650 | 7 | |a J60AR2IKIC |2 NLM | |
| 650 | 7 | |a Paliperidone Palmitate |2 NLM | |
| 650 | 7 | |a R8P8USM8FR |2 NLM | |
| 700 | 1 | |a Ben Rejeb, H |e verfasserin |4 aut | |
| 700 | 1 | |a Ateb, S |e verfasserin |4 aut | |
| 700 | 1 | |a Fourati, T |e verfasserin |4 aut | |
| 700 | 1 | |a Chammas, F |e verfasserin |4 aut | |
| 700 | 1 | |a Baha, D |e verfasserin |4 aut | |
| 700 | 1 | |a Rosetti, R |e verfasserin |4 aut | |
| 700 | 1 | |a Kalalou, K |e verfasserin |4 aut | |
| 700 | 1 | |a Saba, G |e verfasserin |4 aut | |
| 700 | 1 | |a Benadhira, R |e verfasserin |4 aut | |
| 700 | 1 | |a Januel, D |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t L'Encephale |d 1946-1947 |g 46(2020), 3S vom: 23. Juni, Seite S126-S127 |w (DE-627)NLM00004962X |x 0013-7006 |7 nnns |
| 773 | 1 | 8 | |g volume:46 |g year:2020 |g number:3S |g day:23 |g month:06 |g pages:S126-S127 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.encep.2020.05.009 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 46 |j 2020 |e 3S |b 23 |c 06 |h S126-S127 | ||